Patents by Inventor Stellar Pharmaceuticals Inc.

Stellar Pharmaceuticals Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYSTITIS TREATMENT WITH HIGH DOSE CHONDROITIN SULFATE
    Publication number: 20130143839
    Abstract: Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400 mg/20 mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particularly in patients with severe and otherwise recalcitrant cystitis.
    Type: Application
    Filed: December 17, 2012
    Publication date: June 6, 2013
    Applicants: Stellar Pharmaceuticals Inc.
    Inventors: Stellar Pharmaceuticals Inc., Peter R. Riehl, Sungtack Samuel Hahn